Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Breast lesion localization methods is a pre-surgery procedure where localization devices, for example radioisotopes, wires, magnetic tracer are utilized to embed into the cancer recognized site to limit non-palpable lesion at the time of surgical excision. This procedure is carried out using surgical guidance systems, for example, mammography, ultrasound, and Magnetic Resonance Imaging (MRI) depending on the type of lesion and its location. Surgical removal of non-palpable lumps can be challenging as it involves locating and removing the entire lump while removing the smallest amount of healthy tissue possible and maintaining optimal breast appearance. The commonly used technique in guiding the surgical removal of non-palpable breast lumps is wire-guided localization.
The demand for breast lesion localization procedure is growing due to the high prevalence of breast cancer across the globe. Breast cancer is the most frequent cancer among women. As per World Health Organisation Data, breast cancer is impacting 2.1 million women each year. In 2018, it is estimated that 627,000 women died from breast cancer. The breast cancer mortality rate is approximately 15% of all cancer deaths among women. While breast cancer rates are higher among women in more developed regions, rates are increasing in nearly every region globally.
In addition, launch of technological advanced modalities and rising healthcare expenditure in developing economies is also boosting the growth of the breast lesion localization market across the globe fuel the market growth. However, high cost and stringent regulatory approval processes are expected to challenge the Breast Lesion Localization Methods Market growth.
The global Breast Lesion Localization Methods Market is segmented by product type and geography.
Breast Lesion Localization Methods market by product type is categorised into Wire Localization, Radioisotope Localization, Magnetic Tracers and Other Localization Methods. Radioisotope Localization segment is further categorised into Radioactive Seed Localization (RSL), Radio Occult Lesion Localization (ROLL) and others. Wire localization segment held the significant revenue of the market. The significant market share of the segment is attributed to the early establishment and higher adoption of this technique among end-users. Some of the widely used wire localization devices includes RPLN, Q-wire system, and Duo-System among others. Further, the radioisotope segment is anticipated to witness a lucrative growth over the forecast period as it is one of the latest techniques that offers effective, safe, method for preoperative localization of non-palpable, suspicious lesions.
The breast imaging market is segmented into four regional segments, namely, North America, Europe, Asia Pacific and the Rest of the World. North America dominated the global Breast Lesion Localization Methods Market in 2018. The large share of the market is attributed to the factors such as the rising incidence of breast cancer coupled with the easy accessibility and high adoption of advanced diagnostic technologies, significant per capita annual healthcare expenditure in the US and Canada, and the rapidly increasing geriatric population in the region.
However, the Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. A number of factors, such as the growing patient populace, improving healthcare infrastructure, rising government spending on breast cancer research studies, growing healthcare expenditure and implementation of several initiatives to create awareness for the detection and treatment of breast cancer are expected to drive the market in the Asia-Pacific region during the forecast period.
The major players in Breast Imaging Technologies includes C.R. Bard, Ranfac Corporation, Invivo Corporation, SOMATEX Medical Technologies GmbH, Argon Medical Devices, SurgicEye GmbH, GE Healthcare, Intra-Medical Imaging LLC, IsoAid, LLC, NuclearLab S.R.L, Cianna Medical , Endomagnetics Ltd. And Cook Medical among others. The market players are focusing on business expansion in developing regions in an attempt to increase their market share. They have also undertaken several other strategies, such as mergers and acquisition and product launches.
The global breast lesion localization methods market is segmented on the basis of type and geography.
Breast Lesion Localization Methods market by product type is categorised into Wire Localization, Radioisotope Localization, Magnetic Tracers, Other Localization Methods. Radioisotope Localization segment is further categorised into Radioactive Seed Localization (RSL), Radio Occult Lesion Localization (ROLL) and Others. Geographically, the market is analysed across regions, such as North America, Europe, Asia-Pacific, and Rest of the World
The major players in Breast Imaging Technologies includesC.R. Bard, Ranfac Corporation, Invivo Corporation, SOMATEX Medical Technologies GmbH, Argon Medical Devices , SurgicEye GmbH , GE Healthcare, Intra-Medical Imaging LLC, IsoAid, LLC, NuclearLab S.R.L, Cianna Medical , Endomagnetics Ltd. And Cook Medical among others.
Why to buy this report: